NM_000548.5:c.5097G>C

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_000548.5(TSC2):​c.5097G>C​(p.Val1699Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,612,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V1699V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

TSC2
NM_000548.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: 1.11

Publications

1 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 16-2088076-G-C is Benign according to our data. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088076-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.11 with no splicing effect.
BS2
High AC in GnomAdExome4 at 20 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC2NM_000548.5 linkc.5097G>C p.Val1699Val synonymous_variant Exon 40 of 42 ENST00000219476.9 NP_000539.2 P49815-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkc.5097G>C p.Val1699Val synonymous_variant Exon 40 of 42 5 NM_000548.5 ENSP00000219476.3 P49815-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152166
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000439
AC:
11
AN:
250416
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000885
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.0000137
AC:
20
AN:
1460510
Hom.:
0
Cov.:
32
AF XY:
0.00000963
AC XY:
7
AN XY:
726584
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33470
American (AMR)
AF:
0.000335
AC:
15
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39664
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52130
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1111982
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152166
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41432
American (AMR)
AF:
0.0000654
AC:
1
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000718

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tuberous sclerosis 2 Benign:3
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 06, 2025
Myriad Genetics, Inc.
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

Tuberous sclerosis syndrome Benign:1Other:1
Feb 05, 2024
All of Us Research Program, National Institutes of Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Tuberous sclerosis database (TSC2)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

not specified Benign:1
Aug 26, 2022
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Jan 14, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
6.9
DANN
Benign
0.60
PhyloP100
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397515314; hg19: chr16-2138077; API